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Abstract 
The secondary palate separates the oral from the nasal cavity and its closure during 
embryonic development is sensitive to genetic perturbations. Mice with deleted Foxf2, 
encoding a forkhead transcription factor, are born with cleft palate, and an abnormal 
tongue morphology has been proposed as the underlying cause. Here, we show that 
Foxf2-/- maxillary explants cultured in vitro, in the absence of tongue and mandible, failed 
to close the secondary palate. Proliferation and collagen content were decreased in 
Foxf2-/- palatal shelf mesenchyme. Phosphorylation of Smad2/3 was reduced in mutant 
palatal shelf, diagnostic of attenuated canonical Tgfβ signaling, whereas phosphorylation 
of p38 was increased. The amount of Tgfβ2 protein was diminished, whereas the Tgfb2 
mRNA level was unaltered. Expression of several genes encoding extracellular proteins 
important for Tgfβ signaling were reduced in Foxf2-/- palatal shelves: a fibronectin splice-
isoform essential for formation of extracellular Tgfβ latency complexes; Tgfbr3 – or 
betaglycan – which acts as a co-receptor and an extracellular reservoir of Tgfβ; and 
integrins αV and β1, which are both Tgfβ targets and required for activation of latent 
Tgfβ. Decreased proliferation and reduced extracellular matrix content are consistent 
with diminished Tgfβ signaling. We therefore propose that gene expression changes in 
palatal shelf mesenchyme that lead to reduced Tgfβ signaling contribute to cleft palate in 
Foxf2-/- mice. 
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Introduction 
Cleft palate, with or without cleft lip, is a common congenital malformation in humans 
with one out of 500 to 2500 newborns affected, depending on population. The high 
incidence reflects the complexity of the morphogenetic process and its underlying 
genetics; around 500 syndromes have been described that involve cleft palate (Dixon et 
al., 2011). Secondary palate development requires growth, elevation, and fusion of the 
palatal shelves in order to delimit the nasal from the oral cavity, and defects in any of 
these processes result in persistence of a cleft along the midline (Bush and Jiang, 2012). 
In mouse, formation of the secondary palate begins at embryonic day 11.5 (E11.5) 
with palatal shelves growing out of the maxillary processes as anteroposterior ridges. The 
shelves are composed of ectomesenchyme, derived from cranial neural crest (Ito et al., 
2003), and are covered by an ectodermal epithelium. Initially, the palatal shelves grow 
vertically down the sides of the tongue, but around E14 elevate to a horizontal position 
above the tongue and continue to grow horizontally, until they appose and fuse along the 
midline. A transient epithelial seam is formed which is gradually replaced by continuous 
mesenchyme (Vaziri Sani et al., 2005). Rostrally, the secondary palate fuses with the 
primary palate and the nasal septum, thereby creating the separation between the oral 
cavity and the two nostrils. In rodents, which are obligatory nose breathers, cleft palate is 
fatal due to its interference with breathing and suckling, and affected pups die shortly 
after birth with air filled guts. For a review of secondary palate development and 
disorders, see e g Bush and Jiang (2012). 
Extracellular matrix (ECM) proteins are important for survival and continued 
proliferation of the palatal mesenchyme, as well as for expansion of the palatal shelves. 
Matrix accumulation and cell proliferation have been estimated to account for 
approximately equal shares of the volume increase of the palatal shelf tissue (Ferguson, 
1988). The dominating ECM molecules in the developing palate are glycosaminoglycans 
(GAG), collagens and fibronectin. GAG consist mainly of hyaluronan, heparan sulphate 
and chondroitin sulphate, which hold up to ten times their mass in water and cause 
expansion of the palatal tissue through swelling (Foreman et al., 1991). This mechanism 
is utilized during elevation of the shelves from their initial vertical to their final 
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horizontal position, by asymmetrical deposition of hyaluronan (Ferguson, 1988; 
Moxham, 2003). The most abundant collagens are types I, III and V, which are 
distributed throughout the palatal mesenchyme, and IV which is associated with blood 
vessels and the sub-epithelial basement membrane (Ferguson, 1988; Foreman et al., 
1991; Silver et al., 1981). Genetic and in vitro data show the importance of collagens for 
several steps in palatal development, including elevation, growth and fusion (Aszodi et 
al., 1998; Ferguson, 1988). Several paracrine factors stimulate the accumulation of ECM, 
where Tgfβ increases production of collagens, whereas Egf mainly induces synthesis of 
GAG (Ferguson, 1988; Foreman et al., 1991; Moxham, 2003). However, since the 
secretion of matrix degrading metalloproteinases is controlled partly by the same factors 
(Miettinen et al., 1999), the net effect on ECM accumulation is not always obvious.  
The transforming growth factor β isoforms Tgfβ1 and -3 are expressed in the palatal 
epithelium, whereas Tgfβ2 is found exclusively in the mesenchyme (Fitzpatrick et al., 
1990; Pelton et al., 1990). Their receptors are present, and important, in both tissues: 
neural crest-specific inactivation of the Tgfβ type II receptor gene, Tgfbr2, causes cleft 
palate associated with reduced proliferation in the shelf mesenchyme (Ito et al., 2003), 
whereas conditional targeting of the same receptor in the epithelium instead hindered 
fusion of the palatal shelves by preventing elimination of the medial epithelial seam (Xu 
et al., 2006).  
Fibroblast growth factors (Fgf) 8, 9, 10 and 18 are all required for normal palate 
development (Abu-Issa et al., 2002; Alappat et al., 2005; Colvin et al., 2001; Frank et al., 
2002; Liu et al., 2002; Ohbayashi et al., 2002; Rice et al., 2004) and signals through the 
receptors Fgfr1 and -2 (Rice et al., 2004; Trokovic et al., 2003). Fgf10 is expressed in the 
mesenchyme, from where it activates expression of Sonic hedgehog (Shh) in the 
epithelium, which in turn targets the sub-epithelial mesenchyme (Lan and Jiang, 2009; 
Rice et al., 2004). Shh from the pharyngeal endoderm and the oral ectoderm is essential 
for proliferation and survival of cranial neural crest mesenchyme and induces patterning 
of the craniofacial area by activation of genes encoding forkhead transcription factors 
(Jeong et al., 2004).  
Peter	  Carlsson,	  Cleft	  palate	  manuscript,	  16-­‐05-­‐09,	  13.34	   p5	  (of	  27)	  
The forkhead genes Foxf1 and Foxf2, encode closely related transcription factors and 
are expressed in the splanchnic and extraembryonic mesoderm, and their derivatives 
(Aitola et al., 2000; Hellqvist et al., 1996; Mahlapuu et al., 1998; Peterson et al., 1997; 
Pierrou et al., 1994). In terms of expression level, Foxf1 dominates during early 
embryogenesis and in the foregut, whereas both genes are highly expressed in the gut 
mesenchyme during organogenesis (Ormestad et al., 2004). Foxf1 null mutants die at mid 
gestation due to severe defects in the extraembryonic vasculature (Astorga and Carlsson, 
2007; Mahlapuu et al., 2001b), and heterozygotes suffer from a haploinsufficiency 
affecting the lungs and foregut (Kalinichenko et al., 2001; Mahlapuu et al., 2001a). Foxf2 
null mutants have developmental defects of the gut and die at birth (Ormestad et al., 
2006). In adults Foxf2 limits the size of the intestinal crypt stem cell niche through 
inhibition of Wnt signaling (Nik et al., 2013), and maintains the blood-brain barrier 
through activation of vascular Tgfβ and Pdgfrβ signaling in CNS pericytes (Reyahi et al., 
2015). Both FoxF genes are expressed in cranial neural crest cells of the maxillary and 
mandibular components of the branchial arches (Jeong et al., 2004), Foxf2 as early as 
onset of the delamination of neural crest from the neural tube (Ormestad et al., 2004), 
whereas Foxf1 is activated when the cells reach the branchial arches. Both the 
maintenance of Foxf2 expression and the activation of Foxf1 in cranial neural crest cells 
require Shh from the pharyngeal endoderm, or the oral ectoderm (Jeong et al., 2004; Lan 
and Jiang, 2009). Activation or maintenance by hedgehog signaling is a prerequisite for 
FoxF expression also in gut, lung, lateral plate and yolk sac mesoderm (Astorga and 
Carlsson, 2007; Madison et al., 2009; Mahlapuu et al., 2001a; Ormestad et al., 2006, and 
unpublished data).  
Foxf2-/- mutants die at birth with cleft secondary palate (Wang et al., 2003). The 
proposed mechanism suggests the mutant palatal tissue retains the same proliferation rate 
as in wild-type, but an abnormal tongue morphology prevents elevation of the palatal 
shelves, thereby obstructing palatal fusion (Wang et al., 2003). Here, we provide 
evidence for a defect intrinsic to the palatal shelf mesenchyme with Foxf2 required for 
normal Tgfβ signaling, proliferation, and collagen accumulation. 
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Materials and Methods 
Mouse strains 
The Foxf2 knockout (MGI:2667134) from the Miura lab (Wang et al., 2003) and our 
conditional Foxf2fl allele (Reyahi et al., 2015) have been described elsewhere. A novel 
constitutive null allele was generated from Foxf2fl by crossing with Myh11-Cre (Xin et 
al., 2002), which acts as a germ line deleter when maternally inherited. Myh11-Cre 
(MGI:2653286), Wnt1-Cre (MGI:2386570) and the double fluorescent reporter strain 
mTmG (MGI:3716464) were obtained from Jackson Lab (Maine). All strains were 
maintained on C57Bl/6J background. 
Whole mount in situ hybridization and lacZ staining 
Embryos were processed for whole mount in situ hybridization as described 
previously (Blixt et al., 2000) and hybridized with digoxigenin labeled antisense RNA 
probes for Foxf1 (Mahlapuu et al., 2001b) and Foxf2 (Ormestad et al., 2004). Vibratome 
sectioning of whole mount hybridized embryos was performed according to Landgren 
and Carlsson (2004). 
BrdU analysis, immunohistochemistry and histology 
For proliferation assays, E13.5 pregnant females were injected intraperitoneally with 
BrdU (Sigma; 100 µg/g body weight) and embryos were dissected and fixed exactly one 
hour later. Anti-BrdU (Pharmingen) was visualized by horseradish peroxidase (HRP) 
secondary antibodies and diaminobenzidine (DAB). BrdU positive and negative nuclei 
were counted in palatal shelf epithelium and in mesenchyme of tongue and palatal 
shelves from sections counterstained with Richardson’s Methylene Blue/Azur II at 
different levels along the anteroposterior axis. Three intra-litter pairs of wild-type and 
Foxf2-/- embryos were analyzed and the proliferation index for each level was based on 
the average of 6 slides.  
For immunohistochemistry and histology, embryo heads were fixed in 4% buffered 
paraformaldehyde, and serially sectioned (coronal section, paraffin). Sections were 
stained with hematoxylin and eosin (H&E), or with antibodies directed against Foxf1 
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(R&D Systems), Foxf2 (R&D Systems), or collagen type I (Biomex). Antigen retrieval 
was carried out by pressure boiling in Tris-EDTA buffer pH 8.0. 
Explant cultures 
Heads of E13.5 embryos, from which the mandible, tongue and most of the brain had 
been removed, were cultured for 24 hours in rotating vials at 37°C in 5% CO2, 100% 
humidity. During culture, the explants were suspended in serum-free F12 medium 
(Invitrogen), supplemented with streptomycin/penicillin (50U/ml), 0.2 mg/ml ascorbic 
acid and 0.1% BSA. Alternatively, palatal shelves were dissected and placed on MF 
filters (Millipore), supported by stainless grids in an air/medium interface and cultured 
for 48 hours in the same medium and atmosphere as for the suspension culture. 
Extracellular matrix quantification 
Palatal shelves were dissected from E13.5 embryos. Samples were weighed (fresh) 
and processed for measuring total collagen content with a soluble collagen assay (Sircol, 
Biocolor) following the manufacturers instructions. Quantification was made 
spectrophotometrically and calibrated with a collagen standard curve. GAG content was 
measured in a similar manner with a separate kit (Blyscan, Biocolor).  
Western blot 
Whole tissue extracts were prepared from E13.5 palatal shelves and protein 
concentration determined by Bradford assay (Biorad). Samples were run on 
polyacrylamide gels, blotted onto membranes and probed with antibodies against 
fibronectin (Sigma), Tgfβ2 (Santa Cruz), Smad2/3 (Cell Signaling), phosphorylated 
Smad 2/3 (Santa Cruz), p38 (Cell Signaling), phosphorylated p38 (Cell Signaling), and β-
actin (mouse monoclonal, Sigma).   
mRNA quantification by qPCR 
Quantification of mRNA by PCR was performed on an Applied Biosystems instrument as 
described previously (Landgren et al., 2008). Briefly, cDNA synthesis was carried out 
using the Fermentas Revert Aid TM Premium First Strand cDNA synthesis kit and 
analyzed with Power CYBR Green qPCR master mix from Applied Biosystems. Primers 
(Tab S1) were designed in house, or taken from online resources. Each sample was 
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analyzed in triplicate and normalized against the 36B4 transcript (Akamine et al., 2007). 
The number of biological replicates varied, but was never less than five per genotype.  
Statistical analysis 
Two-tailed Student’s t-test with variances assumed equal, was used to compare averages. 
Fractions (percentages) were arcsine transformed when required to obtain a normal 
distribution of data points. 
Results 
Foxf1 and -2 expression partially overlap in the developing palate 
Both FoxF genes are expressed in the mesenchyme of the oral cavity and the tongue 
(Aitola et al., 2000; Jeong et al., 2004; Mahlapuu et al., 1998; Wang et al., 2003) and, 
given their partially redundant function in other organs (Ormestad et al., 2006), we 
wanted to investigate to what extent expression of Foxf1 and -f2 overlap in the 
developing palate. Whole mount in situ hybridization showed that Foxf2 mRNA 
dominates in the posterior palatal shelves during E12.5–14.5, whereas Foxf1 expression 
is more lateral, does not extend as far posteriorly, and is most prominent around tooth 
buds (Fig 1A, B). Upon fusion of the central part of the palate, at E14.5, Foxf2 expression 
adopts a striped pattern, reflecting the development of the palatal rugae, and from E15.5 
expression of both FoxF genes decreases significantly, with low expression persisting in 
the rugae. In addition to the palatal shelves, Foxf2 mRNA is abundant in the ventral part 
of the nasal septum and in the tongue (Fig 1B, C).  
The pattern observed by in situ hybridization was confirmed and further refined by 
immunohistochemistry on sections with antibodies to Foxf1 and -f2 (Fig 1D–K). Of 
particular interest is the difference in protein distribution in the posterior part, where 
Foxf1 staining is prominent around the tooth buds, but weak in the palatal shelves, 
whereas Foxf2 is abundant in the shelf mesenchyme. This difference is evident at E12.5, 
but particularly striking at E13.5 (compare bottom rows of Fig 1D/E and F/G). In 
contrast, the distribution of two proteins is similar in the maxilla, mandible and tongue at 
the level of the anterior molar bud, particularly at E12.5, but also at E13.5 (compare 
middle rows of Fig 1D/E and F/G). The tissue involved in palatal closure thus varies 
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considerably along the anteroposterior axis with respect to degree of overlap between 
Foxf1 and -f2 expression, but displays significant differences at the critical E13.5 stage.  
At no stage or location were any of the FoxF proteins detected in epithelial cells, 
consistent with previous observations and the situation in other organs. The subepithelial 
mesenchyme of the tongue stained intensely for both proteins at all stages (E12.5–14.5) 
and at all levels along the anteroposterior axis (Fig 1D–K).  
Cleft palate in Foxf2-/- mutants 
During analysis of the gut defect of E18.5 Foxf2-/- mutants, we confirmed the cleft in 
the secondary palate (Fig 2D, F, L), previously described for this mutant (Wang et al., 
2003). Wang et al (2003), reported complete penetrance for this malformation, whereas 
we initially observed a normal, fused palate in approximately 5% of Foxf2 null mutants 
on C57Bl/6J background. During continued breeding on the same strain, the penetrance 
dropped to 80%, and has remained stable at this level for the last years. Genotypes are 
produced in normal Mendelian ratios and homozygous knockout embryos with and 
without the cleft palate occur in the same litters. In spite of extensive breeding, no 
Foxf2-/- animals survived to the age when pups are genotyped (2–3 weeks). Presumably 
the gut and/or cerebrovascular defects are fatal even in cases where the palatal are not; an 
interpretation supported by the perinatal death of Foxf1/Foxf2 compound heterozygotes, 
which have similar intestinal malformations, but normal palate (Ormestad et al., 2006).  
Most of the analysis described in this paper was performed on the original Foxf2 null 
allele from Miura and co-workers (Wang et al., 2003). We obtained a second constitutive 
null allele by Cre mediated germ line-deletion of exon 1 from our conditional Foxf2 allele 
(Reyahi et al., 2015). A limited number of litters have been analyzed, but so far all E18.5 
embryos homozygous for this null allele had cleft palate and appeared indistinguishable 
from the Miura null mutants. This confirms that clefting is caused by inactivation of 
Foxf2, rather than a linked secondary mutation. 
A developmental defect intrinsic to the Foxf2-/- palatal tissue 
To investigate if the cleft palate of Foxf2 null mutants involves altered development of 
the palatal shelves, rather than just obstruction by the tongue, we attempted to separate 
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the role of Foxf2 in the two tissues. First, we conditionally targeted Foxf2 in neural crest 
cells, using Wnt1-Cre (Danielian et al., 1998), which deletes Foxf2 in the palatal shelf 
mesenchyme, while leaving it intact in all epithelia and in the mesodermally derived 
muscle cells of the tongue. Mice homozygous for the floxed allele (Foxf2fl/fl) were 
crossed with Foxf2-/+; Wnt1-Cre. The specificity of the Cre driver and the ontogeny of the 
relevant cell populations were verified by examination of E13.5 and E18.5 embryos 
double transgenic for Wnt1-Cre and the dual fluorescent marker mTmG (Muzumdar et al., 
2007). The mesenchyme of the palatal shelves (E13.5) and secondary palate (E18.5) was 
completely recombined (green fluorescence; Fig 2I, J) with only blood vessels (which do 
not express Foxf2 (Reyahi et al., 2015)) remaining non-recombined (red fluorescence). 
The oral, nasal and tongue epithelia also remained non-recombined, as did the muscle 
cells of the tongue. At E18.5 the tongue is dominated by muscle, but also contains 
connective tissue of neural crest origin (green fluorescence in Fig 2J). At E13.5 both cell 
types are present in the tongue, but the relative contribution of neural crest cells is 
significantly higher (Fig 2I). Foxf2fl/-; Wnt1-Cre mutants developed cleft palate (Fig 2H, 
N), indistinguishable from that of the null mutant (Fig 2F, L), whereas all other 
genotypes in these litters, including Foxf2fl/+; Wnt1-Cre and Cre negative Foxf2fl/-, had 
closed palates (Fig 2G, M and data not shown).  
Although this result showed that inactivation of Foxf2 in the tongue musculature was 
not required for clefting, the substantial contribution of neural crest derived mesenchyme 
to the E13.5 tongue meant that alterations in tongue morphology might still be involved. 
Furthermore, the asymmetry in tongue morphology seen in many Foxf2-/- mutants from 
E14.5 onwards (Fig 1K; 2D, F) occured also in Foxf2fl/-; Wnt1-Cre mutants (Fig 2H). 
As an independent approach, we in vitro-cultured explants consisting of E13.5 heads, 
from which the mandible, the tongue and the majority of the brain had been removed. 
Deformation of the tissue was prevented by maintaining the explants in suspension 
through constant rotation. After 24 hours in culture, the palatal shelves of wild-type 
explants had fused in the central portion of the palate, with anterior and posterior gaps 
remaining (Fig 2O). This corresponds to the stage of early E14.5 embryos and showed 
that palatal development in vitro under these culture conditions mimics that of the in vivo 
situation, but proceeds somewhat slower. In contrast to wild-type, Foxf2-/- explants 
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remained open (Fig 2P). This result supports the notion of reduced growth in 
Foxf2-/- palatal shelves, which causes failure to close even in the absence of the tongue. 
When E13.5 maxillary explants were instead cultured for twice the time (48 hours) on a 
permeable filter, which supports the tissue and facilitates horizontal growth, wild-type 
and Foxf2-/- explants alike formed a continuous tissue of merged palatal shelves. Sections 
of these explants confirmed that fusion had occurred and that the midline epithelial seam 
had disappeared (Fig 2Q, R). The fate of the midline edge epithelium of Foxf2 mutants is 
thus comparable to that of controls under conditions where growth of the palatal shelves 
is sufficient to close the gap. This is consistent with the apparently normal palate of the 
up to 20% of Foxf2 null mutants in which clefting is not penetrant.  
To understand through which mechanism Foxf2 affects palate development, we next 
focused on the two processes known to be most important for palatal shelf expansion: 
cellular proliferation and accumulation of extracellular matrix. 
Reduced collagen content in Foxf2-/- palatal shelves 
Accumulation of ECM is an important component of palatal growth and two classes of 
matrix molecules dominate quantitatively: collagens and glycosaminoglycans (GAG). 
Immunostaining of sections from E13.5 embryos with an antiserum against a fibrillar 
collagen (type I) showed this ECM molecule to be abundant and ubiquitously distributed 
in the palatal shelf mesenchyme (Fig 2S, left). The staining was somewhat weaker in the 
Foxf2 mutant than in wild-type posterior palatal shelves (Fig 2S). To corroborate the 
immunostaining data with a quantitative method, we used a spectrophotometric assay to 
measure the total collagen content of E13.5 palatal shelf tissue. The wild-type palates 
contained significantly more (61%, p=0.02, n=10) collagen than the Foxf2 mutant (n=6), 
per mg of tissue (Fig 2T). A similar assay was used to measure the content of GAG. The 
modest reduction in GAG content in the Foxf2 mutant (20%) was not statistically 
significant (p=0.22; n=5 for each genotype). However, the inter-individual variation and 
limited sample size would allow a potentially relevant difference to go undetected.  
Decreased mesenchymal proliferation in Foxf2-/- palatal shelves 
Up until approximately E13.5, development of the palatal shelves in Foxf2-/- embryos 
paralleled that of their wild-type litter mates, but during the subsequent 24 hours there 
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was a clear difference in morphogenesis (Fig 2A–D). Hence, E13.5 offers the latest 
opportunity to analyze comparable tissues, but ought to reveal a difference in 
proliferation, if present. To quantify cell proliferation, E13.5 embryos were collected one 
hour after BrdU injection of pregnant females. Coronal sections at different levels along 
the anteroposterior axis were scored for BrdU-positive and negative nuclei in epithelium 
and mesenchyme of the palatal shelves, and in the tongue mesenchyme (Fig 3). BrdU 
index of tongue mesenchyme (from the dorsolateral corner of tongue cross sections at 
levels corresponding to A/D and B/E in Fig 3) did not differ between genotypes (Fig 3G). 
Proliferation in epithelium was identical between genotypes at the level of the first molar 
buds (middle level; B/E/H/J in Fig 3). At the posterior level (C/F/I/K in Fig 3) Foxf2-/- 
epithelium had fewer BrdU+ cells (14.3% vs 18.4% in wild-type), but the low number of 
cells meant higher stochastic variation and the difference was not statistically significant. 
In palatal shelf mesenchyme, proliferative cells were significantly fewer in Foxf2-/- 
mutants at the posterior level (27,6% vs 39.0% in wild-type; p=0.0015; Fig 3C, F, G, I, 
K), but did not differ between genotypes at the middle level (26.2% vs 27.3%; Fig 3B, E, 
G, H, J). Posterior shelf mesenchyme was scored separately adjacent to the oral and nasal 
epithelia, but did not differ significantly (39.5% vs 28.2% for oral mesenchyme and 
38.5% vs 27.0% for nasal) and the data were pooled for the analysis in Fig 3G. 
Attenuated Tgfβ signaling in Foxf2-/- palatal shelves 
Decreased mesenchymal cell proliferation, together with a reduction in collagen 
accumulation, are likely proximate causes of cleft palate in Foxf2 mutants. The link to 
Foxf2 could either be direct, cell autonomous, or be mediated by any of the paracrine 
signaling pathways that are important for proliferation and matrix production in the 
developing palate. Given the important role of the Tgfβ pathway for palatal mesenchyme 
proliferation and collagen production, we investigated canonical Tgfβ signaling, 
measured as Smad2/3 phosphorylation by western blot. P-Smad2/3 was consistently 
attenuated in E13.5 Foxf2-/- palatal shelves, whereas the level of total Smad2/3 protein 
was comparable to wild-type (Fig 4A). In contrast, the activity of the Smad independent 
Tgfβ pathway mediated by Traf6/Trak1/p38, which antagonizes the canonical pathway in 
palatal development (Iwata et al., 2012), was increased in Foxf2 mutant palatal shelves, 
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as judged by phosphorylation of p38 (Fig 4A). Since Tgfβ is both a mesenchymal 
mitogen (Ito et al., 2003) and an activator of collagen production in the developing palate 
(Foreman et al., 1991), and since abrogation of mesenchymal Tgfβ signaling causes cleft 
palate (Ito et al., 2003), the reduced Smad2/3 phosphorylation is very likely to be relevant 
for the observed malformation in the Foxf2 mutant.  
Reduced level of Tgfβ2 in Foxf2-/- palatal shelves 
Of the three genes encoding Tgfβ ligands, Tgfb2 and -3, are important for palatal 
closure (Kaartinen et al., 1995; Proetzel et al., 1995; Sanford et al., 1997). Tgfb3 is 
expressed exclusively in the epithelium, and its inactivation prevents fusion of the 
epithelia at the midline, without affecting palatal shelf growth (Proetzel et al., 1995). In 
contrast, Tgfb2 is expressed in the palatal shelf mesenchyme and is required for 
proliferation and expansion of the shelves; disruption of this gene leads to palatal clefting 
associated with mesenchymal hypoplasia (Sanford et al., 1997). These distinct roles for 
Tgfβ2 and Tgfβ3 in mesenchyme and epithelium, respectively, are mirrored by the 
consequences of inactivating the Tgfβ type II receptor gene, Tgfbr2, in the shelf 
mesenchyme (Ito et al., 2003), vs targeting of the same receptor in the epithelium (Xu et 
al., 2006). A reduction in Tgfβ2 concentration thus appeared to be a plausible candidate 
for the cause of diminished Smad2/3 phosphorylation, mesenchymal hypoplasia, and 
reduced collagen content of Foxf2 mutant shelves.  
Western blot of extracts from E13.5 palatal shelves indeed showed a significant 
reduction in the amount of Tgfβ2 protein in Foxf2-/- embryos (Fig 4A). With Tgfb2 and 
Foxf2 expressed in the same cells, the most straightforward explanation for this result 
would be for Foxf2 to directly control the transcription of Tgfb2. However, the whole 
mount in situ hybridization described earlier showed no signs of reduced Tgfb2 
expression in Foxf2-/- embryos, and quantification by qPCR confirmed a near wild type 
level of Tgfb2 mRNA (mean ± SEM: 83% ± 7% of wild-type; n=23 wild-type, 24 
Foxf2-/-; p=0.11; Fig 4B). Hence, a post-transcriptional mechanism, such as translation, 
secretion, retention, or degradation, seemed likely to affect the concentration of 
biologically active Tgfβ2 protein, in a Foxf2 dependent manner. 
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Reduced expression of betaglycan, integrins, tenascin and fibronectin in 
Foxf2-/- palatal mesenchyme 
Matrix metalloproteases (MMPs) regulate Tgfβ signaling by cleaving the extracellular 
latency complexes (Ge and Greenspan, 2006), and could potentially be responsible for an 
altered amount of Tgfβ protein in the tissue, without any effect on mRNA. We measured 
the total MMP activity in E13.5 palatal shelves by zymograpy, but found no difference in 
protease activity between extracts from Foxf2-/- and wild-type palatal shelves (Fig S2). 
Thus, altered matrix protease activity does not appear to be responsible for the observed 
reduction of Tgfβ2 protein in the Foxf2 mutant. 
Next, we focused on mechanisms of retention of Tgfβ in the ECM. Tgfβ dimers are 
sequestered in a large latency complex, consisting of a latency-associated peptide (Lap) 
and a latent Tgfβ binding protein (Ltbp), covalently linked to fibronectin and fibrillin 
(Ten Dijke and Arthur, 2007). Fibronectin is critically required for formation of the 
latency complex; fibronectin deficient cells fail to incorporate Ltbp in the ECM, or to 
activate the Tgfβ pathway in response to factors that mobilize latent Tgfβ (Dallas et al., 
2005; Fontana et al., 2005). The Fn1 gene, encoding fibronectin, contains several 
alternatively spliced exons, generating a total of over 20 distinct peptide sequences. One 
of these, the ED-A exon, encodes an integrin binding site and is always absent from 
plasma fibronectin synthesized by the liver, but may or may not be included in tissue 
versions of the protein (Liao et al., 2002). Plasma (i e ∆ED-A) fibronectin could 
efficiently rescue Ltbp incorporation into the ECM of Fn1 null fibroblasts, whereas a 
range of other fibronectin peptides, including a 160 kDa protein that spans all the type III 
repeats and the variable region, but includes the ED-A domain, failed to do so (Dallas et 
al., 2005). The formation of Tgfβ latency complexes thus appears to depend on 
fibronectin versions lacking the ED-A domain (Fig 4C). 
Western blot showed a modest, but consistent, decrease in total fibronectin in E13.5 
palatal shelves from Foxf2-/- embryos, compared to wild-type litter mates (Fig 4D). The 
size difference between versions with and without the ED-A domain is too small to be 
resolved by western blot, but qPCR with primers specific for the +ED-A and ∆ED-A 
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transcripts indicated unaltered levels of +ED-A mRNA, but a 55% decrease in ∆ED-A 
(Fig 4E; p=0.01; n=11 wild-type and 12 Foxf2-/-).  
In addition to its role in formation of the latency complex, fibronectin is also important 
for activation of Tgfβ, as a receptor for integrins. Many integrins, including all αV-
containing heterodimers, are involved in activation of latent Tgfβ1 and Tgfβ3, but not 
Tgfβ2, which lacks the RGD motif in the Lap peptide (Munger and Sheppard, 2011). The 
importance of this step for Tgfβ signaling is illustrated by the Tgfβ1/β3 knockout 
phenocopy of mice lacking the Lap RGD motif (Yang et al., 2007), or integrin αV (Bader 
et al., 1998). Genes encoding several integrin chains, including the αV fibronectin 
receptor, are also transcriptional targets for Tgfβ signaling, which forms the basis for a 
cooperative feed-forward loop of Tgfβ and integrin signaling (Margadant and 
Sonnenberg, 2010; Pechkovsky et al., 2008).  
Foxf2-/- palatal shelves had reduced amounts of mRNA for both chains of the 
dominating integrin, αVβ1, although the reduction in Itga5 was not statistically 
significant (Itgb1: 72% of wild type; p<0.01; Itga5: 60% of wild type; p=0.08; n=8 per 
genotype; Fig 4B). mRNA for Itgb6 and Itgb8 did not differ significantly between 
genotypes (Fig S1). mRNA for Tgfbr3 and Tnc were also significantly reduced in 
Foxf2-/- palatal shelves (Fig 4B). Tnc encodes tenascin c and Tgfbr3 Tgfβ receptor III, 
also known as betaglycan, both large extracellular chondroitin sulfate/heparan sulfate 
proteoglycans. Tenascins synergize with Tgfβ signaling in collagen I biosynthesis, and 
like integrins they are targets of Tgfβ signaling and participate in activation of latent 
Tgfβ. The diverse roles of Tgfbr3 in Tgfβ signaling are not fully understood (Bilandzic 
and Stenvers, 2012), but it binds Tgfβ and presents ligand to the type II receptor 
(Tgfbr2). Notably, the requirement for Tgfbr3 for efficient signaling is most pronounced 
for Tgfβ2 (Lopez-Casillas et al., 1993), and defects in Tgfbr3-/- mice have been attributed 
to defective signaling by Tgfβ2 (Sarraj et al., 2013). No change was seen in expression of 
Tgfbr2 or Alk5 (Fig S1). 
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Discussion  
Foxf2 is a downstream target of an epithelio-mesenchymal crosstalk in the developing 
palatal shelf that starts with Fgf10 from the mesenchyme activating Shh expression in the 
epithelium. Shh activates Foxf2 expression in the mesenchyme and our results now link 
this pathway to expression of several genes of importance for Tgfβ signaling, with 
consequences for collagen accumulation, and mesenchymal proliferation (Fig 5). 
Abrogation of Tgfβ signaling in palatal shelf mesenchyme by targeting Tgfbr2 in neural 
crest leads to upregulation of Foxf2 expression, which suggests a negative feedback 
mechanism. Importantly, genetic inactivation of many components of this chain, 
upstream and downstream of Foxf2, causes cleft palate with mesenchymal hypoplasia.  
Significant reduction of proliferation at E13.5 was detected only in posterior shelf 
mesenchyme. This coincides with the tissue where Foxf2 expression is highest, and 
where there is least overlap with expression of Foxf1. The results are thus consistent with 
partial redundancy of Foxf1 and -f2 in the anterior half of the developing palate. 
The two factors that have been shown to be responsible for rapid expansion of the 
shelves between E13.5 and 14.5 — cellular proliferation and ECM accumulation — are 
both significantly reduced in the Foxf2 mutant, which provides a plausible proximate 
explanation for the developmental defect. Likewise, the reduction in Smad2/3 
phosphorylation and in Tgfβ2 protein level, are entirely consistent with the observed 
phenotype: Tgfβ signaling is known to be a mitogen for palatal shelf mesenchyme and to 
stimulate collagen production. Furthermore, elimination of mesenchymal Tgfβ signaling 
by targeting the only Tgfβ ligand expressed in the mesenchyme, Tgfβ2, or the Tgfβ 
receptor specifically in the mesenchyme, results in a cleft palate phenotype with 
hypoplastic shelves, very similar to the Foxf2 mutant. 
With mRNA for Tgfβ2 unaltered, the mechanism behind the reduction in Tgfβ2 
protein is, however, far from obvious. A wealth of regulated steps intercalate between the 
transcription of Tgfb genes and their biological action, including secretion; intra- and 
extracellular proteolytic processing of pro-peptides; and formation, activation and 
degradation of latency complexes. Furthermore, many of these processes are regulated in 
a tissue specific way, and only partially understood. As a transcription factor with 
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potentially hundreds of target genes, Foxf2 may influence palatal development in general, 
as well as Tgfβ signaling in particular, in several ways.  
One indication that several mechanisms may act in parallel is the observation that 
Tgfb2 null mice have a lower penetrance of cleft palate (23%,Sanford et al., 1997) than 
Foxf2-/- (80–100%). Strain background can have dramatic effects on penetrance 
(Mahlapuu et al., 2001a), and conclusions based on such differences should therefore be 
made with caution, but the higher incidence in Foxf2 mutants suggests that inactivation of 
Foxf2 may have pleiotropic effects on palatal development, of which a reduction in 
Tgfβ2 is one component. The lower penetrance of cleft palate in Tgfb2-/- mice, compared 
to mesenchyme-specific inactivation of the receptor, suggest that Tgfβ1 and Tgfβ3 
produced by the epithelium also target the mesenchymal cells. Activation of Tgfβ1 and 
Tgfβ3 require αV integrins, and the reduction of αVβ1 in Foxf2 null palates may 
therefore aggravate the phenotype. 
The majority of E18.5 Foxf2-/- pups have a wide open gap between the nasal and oral 
cavities, whereas the remainder are, at least superficially, indistinguishable from wild-
type; no intermediates have been observed. This indicates that Foxf2 activity is limiting 
during a short period at the initiation of palatal shelf expansion, and for individuals that, 
for stochastic reasons, manage to pass through this stage with an above-threshold Tgfβ 
signaling level, the remainder of palatal development appears to be robust. Tgfβ is itself a 
potent activator of integrin and fibronectin expression (Hocevar et al., 1999; Varga et al., 
1987). The positive feedback loop this creates (Margadant and Sonnenberg, 2010) is a 
likely mechanistic basis for the all-or-none palatal phenotype of Foxf2 mutants.  
During revision of this paper, Xu et al (2016) published an analysis of the role of 
Foxf2 in palatal development. Their conclusion that Foxf2 mutants have reduced 
proliferation in the palatal shelf mesenchyme that contributes to the cleft palate is 
virtually identical to ours. The genetic approach also suffers from the same limitation as 
ours, i e inability to delete Foxf2 in the palatal shelf without also targeting some of the 
tongue mesenchyme, and persistent tongue abnormalities. In the second part of the paper, 
Xu et al show through an elegant set of experiments how FoxF proteins maintain 
epithelial Shh expression by inhibition of mesenchymal Fgf18. We confirmed their 
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observed increase of Fgf18 mRNA in Foxf2-/- E13.5 palatal shelves (158% ±4% of wild-
type; p<0.01; Fig S1), whereas Fgf10 mRNA did not differ significantly between 
genotypes (wild-type 100% ±7%, n=6; Foxf2-/- 80% ±2%, n=7; mean ±SEM; p=0.08; Fig 
S1). 
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Figure legends 
Figure 1 
Expression of Foxf1 and Foxf2 around the oral cavity E12.5–15.5. A, B. Ventral views 
of maxilla, palatal shelves and palate of E12.5–15.5 embryos hybridized with Foxf1 (A) 
and Foxf2 (B) probes. C. Sections of E12.5 embryo hybridized with Foxf2 probe. A–P = 
anteroposterior axis. D–K. Immunohistochemistry of E12.5 (D, E), E13.5 (F–H) and 
E14.5 (I–K) wild-type (D–G, I, J) and Foxf2-/- (H, K) embryos with Foxf1 (D, F, H, I, K) 
and Foxf2 (E, G, J) antibodies at three levels along the A–P axis.  
 
Figure 2  
Cleft palate in Foxf2-/- mutants. A–H. H&E stained sections of E13.5 (A, B), E14.5 (C, 
D), E18.5 (E, F) and P0 (G, H) wild-type (A, C, E), Foxf2-/- (B, D, F), Wnt1-Cre; 
Foxf2fl/+ (G) and Wnt1-Cre; Foxf2fl/- (H) heads at three levels along the A–P axis. I, J. 
Sections at three levels along the A–P axis of E13.5 (I) and E18.5 (J) heads of Wnt1-Cre; 
mTmG embryos (red = non-recombined, green = recombined). K–N. Ventral views of 
palates of E18.5 wild-type (K), Foxf2-/- (L), Wnt1-Cre; Foxf2fl/+ (M) and Wnt1-Cre; 
Foxf2fl/- (N) embryos. Arrowheads indicate closed (K, M) and open (L, N) secondary 
palates. O, P. Wild-type (O) and Foxf2-/- (P) head explants without tongue and mandible 
cultured in vitro for 24 hours, starting at E13.5. Q, R. Sections of wild-type (Q) and 
Foxf2-/- (R) palatal explants cultured in vitro on filters for 48 hours. Arrowheads indicate 
the midline. S. Immunohistochemical staining of collagen type I in E13.5 palatal shelves 
from wild-type (left) and Foxf2-/- (right) embryos. T. Spectrophotometric quantification 
of collagen content in E13.5 palatal shelves. Means (61% more in wild-type) ±SEM, 
p=0.02, n=10 wild-type and 6 Foxf2-/- embryos. 
Figure 3 
Analysis of proliferation in E13.5 embryos by BrdU incorporation. A–F. Sections of 
wild-type (A–C) and Foxf2-/- (D–F) heads stained with anti-BrdU at three levels along the 
anteroposterior axis. G. Percentage BrdU+ cells in epithelium and mesenchyme of palatal 
shelves, and in tongue mesenchyme. Means of 3 intra-litter pairs of wild-type and 
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Foxf2-/- embryos with value for each embryo and level based on 6 scored sections. Error 
bars = ±SEM. Significant difference between genotypes only observed in posterior 
mesenchyme (p=0.0015). H–K. Close-ups of palatal shelves at the middle (first molar 
bud; H, J) and posterior (I, K) levels of wild-type (H, I) and Foxf2-/- (J, K) embryos. 
Figure 4 
Reduced Tgfβ signaling in Foxf2-/- palatal shelves. A. Western blot with protein 
extracts from wild-type and Foxf2-/- E13.5 palatal shelves showing unaltered levels of 
Smad2/3, p38 and β-actin (loading controls), but reduced level of Tgfβ2, decreased 
phosphorylation of Smad2/3, and increased phosphorylation of p38. B. qPCR 
quantification of mRNA in E13.5 palatal shelves showing near wild-type level in 
Foxf2-/- for Tgfb2, but reduced concentrations for Tgfbr3, Itga5, Itgb1 and Tnc. C. 
Schematic view of fibronectin with the optional ED-A and ED-B domains (top), and two 
splice variants of the 46-exon Fn1 gene. Exons 25 and 33, encoding ED-B and ED-A 
respectively, are indicated with asterisks. D. Western blot with protein extracts from wild 
type and Foxf2-/- E13.5 palatal shelves showing moderately reduced level of fibronectin 
in the mutants (β-actin as loading control). E. qPCR quantification of Fn1 mRNA 
showing no significant difference between genotypes of transcripts that include the ED-A 
exon, but a 55% reduction of ∆ED-A transcripts in Foxf2-/- (p=0.01; n=11 wild type and 
12 Foxf2-/-).  
Figure 5 
Schematic summary of the position of Foxf2 in epithelio-mesenchymal cross talk 
during palatal development, and its relation to major signaling pathways essential for 
closure of the secondary palate. LLC = large latency complex. 
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Fig S2. MMP activity assay. Protein extracts from E13.5 palatal shelves of two wt and 
three Foxf2 knockout embryos analyzed on a 10% Zymogram gelatin gel (Novex). 
Fig S1.  qPCR quantication of mRNA in E13.5 palatal shelves. Left: genes for 
proteins involved in Tgf-beta signaling. None of the dierences between genotypes 
are statistically signicant (p>0.3). The two versions of Tgfbr2 represents two 
alternative splice forms. Right: genes for two Fgf:s. p<0.01 for Fgf18 and p=0.08 for 
Fgf10. n=5 or greater for all assays.
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Table S1 
Primers for qPCR 
Alk5 
Forward: TCT GCA TTG CAC TTA TGC TGA 
Reverse: AAA GGG CGA TCT AGT GAT GGA 
 
Fn1 +ED-A (spans the junction of exons 33 & 34): 
Forward: AAT CCA GTC CAC AGC CAT TC 
Reverse: TTC ATT GGT CCT GTC TTC TC 
 
Fn1 ∆ED-A (spans the junction of exons 32 & 34): 
Forward: GCA GTG ACC ACC ATT CCT G 
Reverse: GGT AGC CAG TGA GCT GAA CAC 
 
Tgfb2, primer set 1 
Forward: CCC CAC ATC TCC TGC TAA TGT T 
Reverse: TCT AAA GCA GTA GGC AGC ATC CA 
 
Tgfb2, primer set 2 
Forward: CTT CGA CGT GAC AGA CGC T 
Reverse: GCA GGG GCA GTG TAA ACT TAT T 
 
Tgfbr2 
Forward: ATG GAA GAG TGC AAC GAT TAC AT 
Reverse: TGG CGC AGT TGT CAC TGA AAT 	  
Tgfbr3 
Forward: CAT CTG AAC CCC ATT GCC TCC 
Reverse: CCT CCG AAA CCA GGA AGA GTC 
 
Itga5 
Forward: CTT CTC CGT GGA GTT TTA CCG 
Reverse: GCT GTC AAA TTG AAT GGT GGT G 
 
Itgb1 
Forward: ATG CCA AAT CTT GCG GAG AAT 
Reverse: TTT GCT GCG ATT GGT GAC ATT 
 
Itgb6 
Forward: CAA CTA TCG GCC AAC TCA TTG A 
Reverse: GCA GTT CTT CAT AAG CGG AGA T 
 
Itgb8 
Forward: AGT GAA CAC AAT AGA TGT GGC TC 
Reverse: TTC CTG ATC CAC CTG AAA CAA AA 
 
Fgf10 
Forward: GCA GGC AAA TGT ATG TGG CAT 
Reverse: ATG TTT GGA TCG TCA TGG GGA 
 
Fgf18 
Forward: CTG CGC TTG TAC CAG CTC TAT 
Reverse: GAC TCC CGA AGG TAT CTG TCT 
 
Tnc 
Forward: ACG GCT ACC ACA GAA GCT G 
Reverse: ATG GCT GTT GTT GCT ATG GCA 	  
